Clinical Trial Update: A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating multiple intravitreal doses of microplasmin for treating vitreomacular traction; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitreomacular Traction

Drugs mentioned

• microplasmin (microplasmin)

Snippet

Sponsor: ThromboGenics | Conditions: Vitreomacular Traction | Phase 2 | Status: COMPLETED | Results posted: 2013-09-13